^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
ADP-A2AFP
i
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Adaptimmune
Drug class:
TCR modulator
Related drugs:
Phase 1
Adaptimmune
Active, not recruiting
Last update posted :
08/29/2022
Initiation :
05/08/2017
Primary completion :
07/07/2021
Completion :
07/07/2036
AFP
|
AFP expression
|
ADP-A2AFP
Share
